Tolid Darou Pharmaceutical Company (DTOLID) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- DTOLID
- Industry
- Pharmaceuticals
- Market
- Iran Fara Bourse
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/09/30 | To 1402/09/30 | To 1401/09/30 | To 1400/09/30 |
|---|---|---|---|---|---|---|
| Operating revenue | 14,768,294 | 4,765,666 | 3,722,336 | 5,366,912 | 3,047,503 | 1,682,012 |
| Cost of operating revenue | -9,279,040 | -4,022,446 | -3,200,415 | -3,729,908 | -2,307,885 | -1,327,042 |
| Gross profit (loss) | 5,489,254 | 743,220 | 521,921 | 1,637,004 | 739,618 | 354,970 |
| Selling, general and administrative expenses | -941,197 | -639,614 | -449,055 | -289,561 | -187,683 | -184,775 |
| Other income | 4,111 | 616 | 2,168 | 31,367 | 80,814 | 54,739 |
| Other expenses | -457,722 | -350,073 | -282,214 | -40,000 | -50,000 | -20,018 |
| Operating profit (loss) | 4,094,446 | -245,851 | -207,180 | 1,338,810 | 582,749 | 204,916 |
| Finance costs | -1,008,062 | -888,516 | -766,412 | -438,183 | -347,929 | -296,321 |
| Other non-operating income and expenses | 21,491 | 40,817 | 1,011,679 | 73,607 | 3,466 | 148,603 |
| Profit (loss) from continuing operations before tax | 3,107,875 | -1,093,550 | 38,087 | 974,234 | 238,286 | 57,198 |
| Current year tax | -699,271 | 0 | -13,497 | 0 | -27,971 | -11,690 |
| Net profit (loss) from continuing operations | 2,408,604 | -1,093,550 | 24,449 | 784,743 | 178,632 | 25,304 |
| Net profit (loss) | 2,408,604 | -1,093,550 | 24,449 | 784,743 | 178,632 | 25,304 |
| Basic earnings (loss) per share | 872 rials | -368 rials | 10 rials | 654 rials | 210 rials | 42 rials |
| Net earnings (loss) per share, rials | 803 rials | -364 rials | 9 rials | 654 rials | 211 rials | 30 rials |
| Capital | 3,000,000 | 3,000,000 | 3,000,000 | 1,200,000 | 850,000 | 850,000 |
Reporting periods
68 periods are on file for this report, from the period ending 1390/12/29 to the period ending 1405/06/31.